| 000 | 01360 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513085000.0 | ||
| 264 | 0 | _c19960313 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0042-9007 | ||
| 024 | 7 |
_a10.1111/j.1423-0410.1995.tb02595.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsujimura, M | |
| 245 | 0 | 0 |
_aHuman parvovirus B19 infection in blood donors. _h[electronic resource] |
| 260 |
_bVox sanguinis _c1995 |
||
| 300 |
_a206-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aAntigens, Viral _xblood |
| 650 | 0 | 4 | _aBlood Donors |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aErythema Infectiosum _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParvovirus B19, Human _ximmunology |
| 650 | 0 | 4 | _aPrevalence |
| 700 | 1 | _aMatsushita, K | |
| 700 | 1 | _aShiraki, H | |
| 700 | 1 | _aSato, H | |
| 700 | 1 | _aOkochi, K | |
| 700 | 1 | _aMaeda, Y | |
| 773 | 0 |
_tVox sanguinis _gvol. 69 _gno. 3 _gp. 206-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1423-0410.1995.tb02595.x _zAvailable from publisher's website |
| 999 |
_c8577791 _d8577791 |
||